Highlighting cross-expression’s biological utility, our network shows that genes Drd1 and Gpr6, which are individually implicated in Parkinson’s disease (PD) and are being pursued as therapeutic targets, are cross-expressed within the striatum, hinting at their joint role in PD pathophysiology. The gene discussed is GPR6; the disease is Parkinson disease.